Supporting the important role of ACLY inhibition in macrophage function, several reports have pointed ACLY as an important target to mitigate in vivo inflammatory complications, such as exposure to lipopolysaccharide and atherosclerosis (Baardman et al., 2020; Lauterbach et al., 2019). This evidence concerns the gene ACLY and atherosclerosis.